Search bioRxiv⌕ Search

Biology subjects

Kjems, J.

Publications and source records attributed to Kjems, J..

At least 19 recordsLinked to original sources

Recipient cell identity governs intracellular transport and membrane interactions of extracellular vesicles across species

Extracellular vesicles (EVs) function as a natural communication system, enabling transfer of biomolecules between cells. Although EVs are produced by nearly all cell types and have shown promise as therapeutic agents, our understanding of how EVs from different cellular origins recognize recipient cells, are taken up, and processed intracellularly remains limited. In particular, it remains unclear whether intracellular EV behavior is primarily governed by EV-intrinsic properties or by the recipient-cell environment. Here, we systematically investigate the relative contributions of EV origin and recipient-cell identity to intracellular EV trafficking. By combining single-vesicle tracking with machine learning-based diffusion-state classification, we analyzed EVs derived from four distinct sources across three recipient cell types over three different time spans. This approach enabled characterization of dynamic transport behaviors, overcoming limitations of traditional ensemble-averaging methods. We observed recipient cell-dependent differences in intracellular trafficking patterns, ranging from relatively uniform and dynamic motion to more heterogeneous and confined behaviors, reflecting variability in intracellular transport environments. Despite these differences, EV origin had only a modest influence on intracellular dynamics following uptake. These findings suggest a model in which intracellular transport arises from an interplay between general EV-associated properties and cell-specific environment.

biophysics↗

Unmasking the diversity of extracellular nucleic acids in the biofilm matrix using nucleic acid-binding dyes

Extracellular nucleic acids (eNA) are central components of bacterial biofilms, contributing to structural integrity, antibiotic tolerance, and emerging functions such as extracellular electron transfer and peroxidase-like catalysis. While extracellular DNA has traditionally been assumed to adopt the canonical B-DNA conformation, biofilms are now known to contain non-canonical structures, including Z-DNA/RNA (Z-NA), G-quadruplex DNA/RNA (G4-NA), and substantial amounts of extracellular RNA. Conventional nucleic acid-binding dyes are widely used for rapid eNA detection, yet their specificity for these diverse structures has not been systematically evaluated. Here, we compare the fluorescence properties of eleven membrane-impermeant dyes (TOTO, BOBO, YOYO, and POPO series, SYTOX Green, SYTOX Red, and propidium iodide) against synthetic B-DNA, Z-DNA, G4-DNA, A-RNA, Z-RNA, and G4-RNA oligonucleotides, with Z-NA stabilised through brominated guanosine analogues synthesised in-house. A clear pattern emerged: green-fluorescent dyes preferentially bound canonical B-DNA, whereas red-fluorescent counterparts displayed broader specificity that extended to non-canonical structures. TOTO-3 and SYTOX Red bound G4-NA with higher fluorescence than B-DNA, and propidium iodide showed an unexpected preference for A-RNA over B-DNA. These observations were validated in Staphylococcus aureus biofilms by parallel immunolabelling with structure-specific antibodies. TOTO-3, YOYO-3, BOBO-3, POPO-3, and propidium iodide reproduced the eNA distribution at the bacterial cell surface. Finally, we introduce poly-A tailing with fluorescently labelled ATP as a stringent, RNA-specific imaging method for biofilms. Together, these results provide practical guidelines for visualising the structural diversity of eNA in biofilms. HIGHLIGHTS- Biofilms contain non-canonical structures of extracellular DNA and RNA - This study tests the ability of DNA-binding dyes to visualise such structures - Propidium iodide visualises RNA with brighter fluorescence than DNA - Red-fluorescent dyes were more versatile than green-fluorescent dyes - Combining several dyes enabled the detection of non-canonical structures

microbiology↗

Expanding the chemical diversity of RNA by transcriptional incorporation of amino acid- and glycosyl-modified nucleotides

With the increasing interest in RNA-based therapies, there is a pressing need to incorporate new chemistries into more complex RNA molecules. These modifications can protect RNA from degradation, improve its pharmacokinetics, and enhance its targeting properties. Here we describe the enzymatic synthesis of chemically modified RNA derivatives using a mutant T7 RNA polymerase to incorporate 23 different base modifications alongside stabilizing ribose modifications, such as 2'-fluoro and 2'-deoxy groups. To investigate the impact on transcription efficiency and fidelity, we employed a pool of 38 template sequences and analyzed the transcripts by next-generation sequencing of the cDNA. Results demonstrated that all modifications were successfully incorporated into RNA, with transcription efficiency influenced by three main factors: type of modification, base modified, and the sequence context. Misincorporation levels during transcription and reverse transcription into cDNA were generally low (<1%) but included noticeable exceptions for some nucleobase-modification combinations. As a robust proof-of-concept we demonstrated the selection of Histidine-U modified aptamer, relying on multiple rounds of transcription and amplification, binding Influenza hemagglutinin protein with low nanomolar KD. We anticipate that this work will significantly contribute to the design and production of chemically modified RNAs with novel functionalities, advancing applications in biomedicine and synthetic biology. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=76 SRC="FIGDIR/small/720138v2_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@29b6daorg.highwire.dtl.DTLVardef@a3c425org.highwire.dtl.DTLVardef@1a27a4aorg.highwire.dtl.DTLVardef@ab0e9_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗

Fluorinated RNA origami enables serum-stable nanodevices for sensing and targeting

Chemically modified RNAs with increased stability and reduced immunogenicity have transformed RNA therapeutics. Rational RNA design methods, including RNA origami, seek to further extend RNA medicine and biotechnology by encoding advanced functions such as signalling, targeting, and controlled release within the RNA polymer. However, current design methods lack the ability to integrate chemical modification or predict how it shapes the structure of large RNA assemblies inhibiting its use in RNA therapeutics. Here we demonstrate that 2-fluoro pyrimidine RNA (FY-RNA) origami structures can be co-transcriptionally folded to generate serum-stable nanodevices. Cryogenic electron microscopy reveals that FY-RNA can alter folding pathways and perturb tertiary motifs, while molecular dynamics simulations show how 2-fluoro modification affects hydrogen bonding, sugar pucker, and helix-helix interactions. Despite these structural perturbations, fluorogenic aptamers embedded within RNA origami retain partial activity and enable logic-based molecular sensing in human serum. Finally, we use an FY-RNA scaffold to determine the structure of an FY-RNA anti-Spike aptamer bound to the Spike protein at 3.4 [A] resolution, uncovering fluorine-specific structural motifs and protein interactions. Together, our results establish design principles for nuclease-resistant RNA architectures and position FY-RNA as a versatile polymer for constructing medical nanodevices and environmental sensors. More broadly, this work provides a framework for systematically exploring the folding landscape of chemically modified RNAs, expanding the chemical and functional diversity accessible to nucleic acid nanotechnology and RNA medicine.

biochemistry↗

Single-Particle Tracking and Positional Phenotyping Reveals Variant-Specific Early Checkpoints in SARS-CoV-2 Cell Entry

SARS-CoV-2 entry is governed by Spike (S) protein-mediated engagement of ACE2 and subsequent activation of either plasma membrane fusion mediated by TMPRSS2 or endocytic uptake. Currently, most insights into these pathways come from bulk assays that obscure the fate of individual virions, thereby concealing intricate mechanistic details that can inform on therapeutic intervention strategies. Here, we applied single-particle fluorescence imaging to directly observe the early checkpoints of SARS-CoV-2 cell entry pathways and separate binding from internalization. Fluorescent virus-like particles (VLPs) pseudotyped with either G614 or Omicron BA.5 S protein variants were imaged on HEK293T-ACE2 (TMPRSS2-negative) and classified at the single-particle level as surface-interacting, crossing, or internal. At baseline, G614 VLPs show higher binding and a larger internalized share than BA.5 VLPs, revealing general divergence in early entry behavior between variants. A trivalent anti-S receptor-binding domain aptamer reduces G614 binding and lowers its internalization. Conversely, the aptamer does not block BA.5 VLP cell binding but increases its internalization efficiency. Pitstop 2, an inhibitor of clathrin-mediated endocytosis, causes no significant change in this observation window, consistent with early clathrin-sensitive events having already progressed. Quantification of trajectories reveals variant-specific mobility: BA.5 displays higher step length than G614, consistent with greater lateral scanning and surface retention. Together, these compact single-particle readouts expose variant-resolved early checkpoints in entry and provide a simple platform to test how ligands and pathway probes shift binding and internalization.

biophysics↗

Native extracellular vesicles display surface bound RNAs that are co-delivered to cells

Extracellular vesicles (EVs) can transport functional RNA between cells and therefore hold great potential for diagnostics and RNA-based therapeutics. Classically, RNA is believed to be encapsulated in the EV lumen. However, it has recently been demonstrated that cells present RNA on their surface. This RNA was found to be glycosylated, and although glycosylated tRNA was also found in EVs, its exact location remained elusive. Here, we demonstrate the presence of RNA on the surface of mesenchymal stem cell (MSC) derived EVs. By combining single-vesicle measurements with direct and selective visualization of RNA, we introduce surface RNA (surfRNA) as a new inherent component of EVs. RNA sequencing supports the surface localization of this RNA and further identifies tRNA fragments as primary constituent of surfRNA. Importantly, surfRNA is co-delivered to target cells together with EVs, suggesting a yet unrecognized uptake route of extracellular RNA. A deeper understanding of the surface-associated RNA may have significant implications for EV biogenesis, targeting, and downstream functional effects. We further envision that these findings are transferable to other nanoparticles and will thereby advance the field of therapeutic RNA delivery.

molecular biology↗

Dedicated nanoparticle flow cytometry for single extracellular vesicle phenotyping: Performance of the CytoFLEX Nano

Accurate discrimination of extracellular vesicles (EVs) from non-vesicular nanoparticles and robust phenotyping of individual EVs directly within complex biofluids are essential to advance understanding of EV biology and to realize their potential as biomarkers and therapeutic agents. Conventional flow cytometers, originally designed for cellular analysis, lack the scatter and fluorescence sensitivity, dynamic range, and event-rate control required for quantitative characterization of nanoscale vesicles and are particularly susceptible to coincident (swarm) detection. Dedicated nanoparticle flow cytometers have been developed to address these limitations, and here we systematically evaluate the suitability of the CytoFLEX Nano (Beckman Coulter) for EV analysis. Using a series of calibration beads of different materials, fluorescent liposomes, and EVs isolated from peritoneal fluid and cell culture medium, we assess size-detection thresholds, scatter and fluorescence sensitivity, dynamic range, and volumetric counting accuracy. These data provide practical guidance for implementing nanoscale flow cytometry in EV research and support the informed adoption of dedicated nanoparticle cytometers in studies adhering to current EV reporting standards.

cell biology↗

A unique mechanism explaining the outstanding performance of a newly discovered doxycycline riboswitch

Synthetic riboswitches offer a versatile and protein-independent solution for conditional gene regulation. They consist of a regulatory domain and an aptamer domain that binds a specific ligand, with their performance largely depending on the ability of the aptamer to control the regulatory domain. Expanding the range of synthetic riboswitches therefore requires the discovery and characterization of new regulatory aptamers. In the present study, we identified a doxycycline-binding aptamer with outstanding regulatory properties in both yeast and human cells which are based on a unique structural dynamic upon ligand binding. Single-molecule force spectroscopy revealed that doxycycline binding strongly stabilizes an intermediate aptamer conformation offering mechanistic insights into its function. The identification of the aptamer through a combination of parallel SELEX and subsequent in vivo screening in yeast, also provided valuable insights into selection dynamics and the first proof for the effectiveness of RNA Capture-SELEX in aptamer selection. Together, the presented data deepen our understanding of regulatory aptamer selection and functionality while adding a high-performing doxycycline-responsive aptamer to the synthetic biology toolbox.

molecular biology↗

Highly controllable co-delivery of siRNA and doxorubicin via cationic niosomes for synergistic anticancer effects

The combination of anticancer drugs and siRNA has emerged as a promising strategy for cancer therapy due to their synergistic effects. However, a major challenge is developing a co-delivery system with high controllability capable of simultaneously encapsulating both the chemical drug and siRNA. In this study, we developed a simple and highly controllable co-delivery system for delivering Doxorubicin (Dox) and siRNA. Co-encapsulation was achieved by intercalating Dox into duplex GC-rich oligodeoxynucleotides, (CGA)7/(TCG)7 (termed CGA-Dox), followed by mixing with siRNA and subsequent condensation using a cationic noisome (SPN) through electrostatic interactions. SPN/siRNA/Dox exhibited efficient cellular uptake and high gene silencing efficiency in both H1299 and MDA-MB-231 cells. Furthermore, co-delivery of Dox and siRNA targeting ribonucleotide reductase subunit M2 (RRM2) using this system significantly enhanced cellular apoptosis and antiproliferative effect in MDA-MB-231 cells compared to Dox alone. These results indicate that our co-delivery system constructed via Dox-DNA intercalation and electrostatic complexation, represents a promising strategy for synergistic anticancer therapy.

bioengineering↗

Optimizing C14120-based LNPs for in vitro and in vivo mRNA delivery

Lipid nanoparticles (LNPs) have proven to be an effective delivery system for RNA therapeutics. The chemical composition of LNPs determines their functional delivery efficiency and targeting properties, which vary between in vitro and in vivo contexts. Here, we have systematically characterized and compared twenty-five novel C14120-based LNP formulations for mRNA delivery in vitro and assessed in vivo mRNA expression and biodistribution using deep sequencing of DNA barcodes in a pooled LNP-mRNA library. In vitro experiments showed correlations of lipid composition with particle size and mRNA transfection efficiency in 4 different cell lines of distinct tissue and species origin. In vivo experiments employed a pooled LNP delivery of luciferase mRNA in combination with a multiplexed barcode system, revealed strong mRNA expression after 6 hours and identified LNP compositions with organ-specific targeting properties. Individual validation of three selected LNP candidates based on mRNA expression analysis confirmed high specificity for the lung-targeting candidate, lower specificity for the liver-targeting candidate, and inconclusive results for the spleen-targeting candidate. These findings identify LNP formulations with promising potential for in vitro and in vivo organ-targeted delivery.

bioengineering↗

Delivery and expression of mRNA therapeutics during ex vivo kidney perfusion: A feasibility study in porcine and human donor kidneys

Achieving efficient mRNA delivery and expression in intact solid organs beyond the liver remains a major challenge for advancing mRNA therapeutics. Normothermic machine perfusion (NMP) provides a clinically relevant ex vivo platform for targeted intervention during donor organ preservation, minimizing systemic exposure and enabling organ-confined mRNA delivery. Here, we demonstrate that intra-arterial infusion of lipid nanoparticles (LNPs) encapsulating reporter mRNAs during kidney NMP enables robust, organ-wide protein expression in human-sized porcine donor kidneys. Engineered LNP formulations were first evaluated for stability and efficacy in kidney cell lines, where LNPs pegylated with TPGS (D--tocopherol polyethylene glycol 1000 succinate) achieved the highest reporter protein expression levels. Next, the LNP-encapsulated mRNAs were introduced into porcine kidneys via a 5-minute infusion during NMP. mCherry and human erythropoietin (hEPO) mRNAs were delivered via the renal artery, serving as intracellular and secreted reporters, respectively. The perfusion was continued for 6-12h after LNP-mRNA infusion with the erythrocyte-based perfusate at 37 {degrees}C. LNP-mRNA administration resulted in widespread parenchymal mRNA uptake and rapid, robust reporter protein expression that continued to increase over the perfusion period. hEPO protein was detected in perfusate and urine, while mCherry expression localized to endothelial and tubular cells within the renal parenchyma. Consistent with the in vitro data, TPGS-LNPs produced the highest expression during NMP. Importantly, LNP-mediated mRNA delivery during NMP did not affect perfusion parameters or histological integrity. These findings demonstrate successful mRNA-driven protein expression in intact donor kidneys, establishing NMP as a clinically relevant route for organ-specific RNA delivery and protein expression modulation. One sentence summaryUsing a clinically compatible normothermic machine perfusion model, we demonstrate that lipid nanoparticle-mediated mRNA delivery enables rapid, organ-wide protein expression in human-sized porcine donor kidneys.

bioengineering↗

Multifunctional semiconducting polymer dots as a miRNA delivery system for osteogenic differentiation and stem cell tracking

Small interfering RNAs (siRNA) and microRNAs (miRNA) are potent gene regulators through RNA interference (RNAi). In this study, we developed a multifunctional theranostic carrier for small RNA delivery and cell tracking using a polymer based nanoparticle composed of the lipid-like material S14, Pluronic F127 and semiconducting polymer MEH-PPV (SPM-dots). The resulting SPM-dots showed efficient siRNA transfection and labeling of human mesenchymal stem cells (hMSCs). Delivery of miR-29b to hMSCs significantly enhanced osteogenic differentiation. Furthermore, hMSCs transfected with SPM-dots displayed strong fluorescent signals in vivo after subcutaneous transplantation. These findings indicate that SPM-dots hold great potential as carrier for gene delivery and cell tracking applications.

bioengineering↗

Bacteriophage-Mimetic DNA Origami Needle for Targeted Membrane Penetration and Cytosolic Cargo Delivery

Inspired by the natural ability of bacteriophages to deliver genetic material directly into host cells, we employed a bottom-up approach to construct a multifunctional synthetic DNA origami needle-like structure. This origami is functionalized with trastuzumab antibodies, cholesterol, protective polymers, and two dyes, which together enable selective targeting and insertion into SKBR3 cancer cells. A disulfide-linked dye payload was attached to the apex of the needle, allowing controlled release in the cytoplasm triggered by the high intracellular glutathione concentration. Real-time tracking of the payload confirmed both successful targeting of the origami structure and subsequent direct cytosolic delivery. By mimicking fundamental mechanisms of bacteriophages, we propose that this artificial needle structure can serve as a prototypical device for the targeted delivery of small-molecule drugs directly into the cytosol.

biochemistry↗

Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platform

The skin is a diverse reservoir of immune cells with strong potential for immunotherapeutic delivery. Langerhans cells (LCs) in the epidermis are antigen-presenting cells, accessible for vaccination using carbohydrate-conjugated therapeutics targeting their endocytic lectin receptor, Langerin. As carbohydrate-lectin binding is highly dependent on valency, scaffolds that enable control over ligand spacing and stoichiometry are instrumental in enhancing receptor binding and selectivity. Here we utilized a self-assembled nucleic acid-based Holliday Junction scaffold, fully modified for nuclease protection and with a well-defined carbohydrate arrangement to optimize drug delivery to LCs. In vitro screening with Langerin-expressing cells revealed that mannosylated Holliday Junctions showed the strongest binding. This was confirmed in human epidermal cell suspensions, demonstrating specificity and valency-driven interactions. Topical administration of mannosylated scaffolds on skin explants enabled effective targeting of epidermal LCs. Finally, in an antigen-presentation assay, in vitro differentiated LCs loaded with mannosylated and peptide-conjugated scaffolds significantly enhanced T cell activation. Overall, our study presents a promising nucleic acid-based platform for precise LC targeting and drug delivery, with broad potential for skin-directed immunotherapies.

molecular biology↗

Nanoscale precise stamping of biomolecule patterns using DNA origami

Understanding the importance of ligand patterning in biological processes requires precise control over molecular positioning and spacing. While DNA origami structures offer nanoscale precision in biomolecule arrangement, their biological applications are limited by challenges related to their structural stability, scalability, and surface area. Here, we present a straightforward and rapid DNA origami stamping technique for transferring nanoscale oligonucleotide patterns onto surfaces, visualized using DNA-PAINT super-resolution microscopy to quantitatively assess the stamping efficiency and precision across different stamp types. Unlike traditional top-down methods that require specialized equipment, our technique provides an accessible, self-assembled platform for surface patterning, with versatility across various substrates via modifiable pattern-transfer oligonucleotides. We demonstrate reliable, efficient, and precise pattern transfer at single-molecule resolution, enabling new opportunities to study distance-dependent biological processes, including receptor activation, multivalent binding, and enzymatic cascades across broader spatial scales and different detection techniques. The use of the passivated surface limits non-specific interactions with unpatterned areas and enables control over the interaction between the biological target and the patterned biomolecules. Our method advances surface patterning by combining DNA nanotechnology with single-molecule imaging techniques, expanding access to cost-effective analytical approaches and potentially enabling multiplexed detection and live measurements.

bioengineering↗

Single-vesicle tracking of α-synuclein oligomers reveals pore formation by a three-stage model modulated by charge, curvature, lipids and ligands

Neurodegenerative disorders like Parkinsons disease (PD) pose significant health challenges. A major hallmark is the aggregation of -synuclein into toxic oligomers (SO) and fibrils. While many efforts focus on slowing disease progression, the molecular origins and mechanisms of SO toxicity remain poorly understood, particularly its proposed link to membrane disruption. To address this, we have developed a single-vesicle analysis platform for direct and real-time measurements of SO and membrane interaction. This allows us to show real-time translocation of dyes through SO pores with single-particle resolution and single-channel electrical recordings for analyzing pore formation in planar lipid bilayers. Across methods, our data reveal evidence for a three-stage model for SO and membrane interactions with initial membrane recruitment followed by partial pore insertion and subsequent full pore formation. Strikingly, while SO recruitment was found to favor curved membranes, pore formation occurred more efficiently in less curved membranes, hence recruitment is divorced from a membrane charge-promoted reorientation and pore integration. Single SO pore formations are undergoing multiple translocation steps hence pore formation is highly dynamic cycling back and forth from partial insertion to full pore formation. The dynamic nature of pore formation can be modulated by lipid charge, lipid headgroup class, and ligand binding. Our findings suggest that increased dynamic pore formation could implies increased membrane toxicity. Evidence for the three-stage model is important for future targeting strategies for blocking SO mitigated PD-related cellular dysfunction and we envision the single-vesicle assay enables screening for ligands modulating the pore formation.

biophysics↗

Lock, Protect, and Bind: In Vitro Selection of LNA-modified Aptamers Using a Mutant T7 RNA Polymerase

RNA therapeutics are powerful tools for gene modulation and targeted therapies, but their clinical application is hindered by nuclease degradation and immunogenicity. Incorporating chemical modifications, like locked nucleic acids (LNAs), can enhance nuclease resistance, targeting properties, and thermal stability. Traditionally, LNA incorporation has relied on solid-phase synthesis of short RNAs. Engineered polymerases capable of incorporating xenonucleic acids (XNAs), including LNA, into longer RNAs have been described. However, their XNA yield is limited by primer and template copy numbers, and the generated DNA-XNA duplexes can be difficult to purify. We present a novel approach for incorporating LNA-ATP and LNA-TTP alongside 2Fluoro (2F)-modified pyrimidines via in vitro transcription using a mutant T7 RNA polymerase. This method enables efficient, primer-independent synthesis and amplification of LNA-modified RNA with low error rates. To demonstrate its utility, we performed in vitro selection (SELEX) of LNA- and 2F-modified aptamers targeting Influenza hemagglutinin (HA) and human CD40 ligand (hCD40L), two therapeutically relevant proteins. Iterative SELEX cycles yielded aptamers with low-nanomolar affinities, high specificity, and high nuclease resistance. Overall, this approach provides a scalable and versatile platform for generating chemically stabilized RNAs, fully compatible with SELEX, and holds potential for developing next-generation RNA-based therapeutics with improved pharmacokinetics.

molecular biology↗

RNA denaturation underlies circular RNA separation

In vitro synthesized circular RNAs (circRNAs) have emerged as a promising drug modality for RNA therapeutics due to their improved stability and reduced immunogenicity. However, effective analysis and purification of circRNAs pose critical challenges arising from the insufficient separation of circRNAs and linear RNA byproducts. In this study, we systematically evaluate the effectiveness of gel electrophoresis and high-performance liquid chromatography - size exclusion chromatography (HPLC-SEC) for separating circRNAs synthesized through ligase- or ribozyme-based strategies. While the synthesis strategy dictates the purification complexity, we demonstrate that both techniques rely on RNA denaturation to successfully separate circRNAs. Additionally, when using HPLC-SEC, we show that even a trace amount of magnesium ions in RNA samples can significantly compromise circRNA separation. Under optimized denaturing conditions, HPLC-SEC enables circRNA purification directly from diluted crude in vitro transcription products, thus streamlining the purification process. Our study provides mechanistic insights into circRNA separation, advancing the purity and scalability of circRNA-based therapeutics. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=81 SRC="FIGDIR/small/631262v1_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@884e54org.highwire.dtl.DTLVardef@ce712corg.highwire.dtl.DTLVardef@16816aforg.highwire.dtl.DTLVardef@a94e58_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗